Instrument Inactif

Communiqués ALPA HEAL

Actions

ALPA

US02073F1049

Communiqués

20/03/24	Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary	AQ
18/03/24	Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field	AQ
26/02/24	Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	AQ
16/11/23	Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors	AQ
16/11/23	ALPA HEAL : Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors - Form 8-K	PU
06/09/23	Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics	AQ
21/07/23	ALPA HEAL : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	PU
17/07/23	Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	AQ
14/07/23	Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	BU
10/07/23	Alpha Healthcare Acquisition III : Material Agreement - Form 8-K	PU
06/07/23	Carmell Therapeutics Merger With Alpha Healthcare Acquisition Corp III (Nasdaq: ALPA) July 6, 2023 - Form 8-K	PU
27/06/23	Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination	BU
02/05/23	ALPHA HEALTHCARE ACQUISITION CORP III : Other Events (form 8-K)	AQ
31/03/23	ALPHA HEALTHCARE ACQUISITION CORP III : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
17/03/23	ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
05/01/23	Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications	BU
04/01/23	ALPHA HEALTHCARE ACQUISITION CORP III : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
10/11/22	ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
11/10/22	Alpha Healthcare Acquisition III : Change in Certifying Accountants - Form 8-K	PU
11/10/22	ALPHA HEALTHCARE ACQUISITION CORP III : Changes in Registrant's Certifying Accountant (form 8-K)	AQ
09/09/22	ALPHA HEALTHCARE ACQUISITION CORP III Other Events, Financial Statements and Exhibits (form 8-K/A)	AQ
09/09/22	ALPHA HEALTHCARE ACQUISITION CORP III : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	AQ
10/08/22	ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
20/05/22	ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
15/04/22	ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ